Cerulean Pharma Inc Share Price Nasdaq
Equities
US15708Q1058
Biotechnology & Medical Research
Sales 2024 * | 15.62M 1.24B | Sales 2025 * | 30.24M 2.4B | Capitalization | 31.68M 2.52B |
---|---|---|---|---|---|
Net income 2024 * | -17M -1.35B | Net income 2025 * | -9M -715M | EV / Sales 2024 * | 2.03 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.05 x |
P/E ratio 2024 * |
-1.97
x | P/E ratio 2025 * |
-3.78
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.35% |
Latest transcript on Cerulean Pharma Inc
Managers | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
FOU | Founder | 57 | 31/12/14 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/21 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robin Steele
BRD | Director/Board Member | 68 | 31/12/14 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 19/11/19 |
Chairman | 76 | 31/12/13 |
1st Jan change | Capi. | |
---|---|---|
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |